98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.joms.2023.02.007 | DOI Listing |
J Allergy Clin Immunol
August 2025
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address:
Front Neurol
February 2025
German Center for Vertigo and Balance Disorders, LMU University Hospital, LMU Munich, Munich, Germany.
Objective: The aim of this world-wide survey was to evaluate the currently applied treatment options for the six most frequent peripheral vestibular disorders: benign paroxysmal positional vertigo (BPPV), acute unilateral vestibulopathy (AUVP)/vestibular neuritis, Menière's disease (MD), bilateral vestibulopathy (BVP), vestibular paroxysmia (VP) and superior canal dehiscence syndrome (SCDS).
Background: For the therapy of vestibular disorders, there are four treatment options: vestibular physical therapy (canalith repositioning maneuvers or balance training), pharmacotherapy, surgery, and psychotherapy. Since there are very few state-of-the-art RCTs, the treatment of vestibular disorders is so far not standardized and various methods are applied with heterogeneous efficacy.
Eur Radiol
June 2025
MRI Unit, Radiology Department, HT Medica, Jaén, Spain.
Clin Nutr
December 2024
General Surgery Unit with Intestinal Failure Center, Stanley Dudrick's Memorial Hospital, Skawina, Poland; Surgical Oncology Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Stanley Dudrick's Memorial Hospital, General Surgery Unit with Intestinal Failure Center, Skawi
J Allergy Clin Immunol Glob
November 2024
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.